| Target Price | $30.60 |
| Price | $10.12 |
| Potential |
202.37%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Akari Therapeutics Plc Sponsored ADR 2027 .
The average Akari Therapeutics Plc Sponsored ADR target price is $30.60.
This is
202.37%
register free of charge
$42.00
315.02%
register free of charge
$27.27
169.47%
register free of charge
|
|
| A rating was issued by 10 analysts: 9 Analysts recommend Akari Therapeutics Plc Sponsored ADR to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Akari Therapeutics Plc Sponsored ADR stock has an average upside potential 2027 of
202.37%
register free of charge
|
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Maxim Group |
Locked
➜
Locked
|
Locked | Jul 20 2026 |
| Maxim Group |
Locked
➜
Locked
|
Locked | Apr 08 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 01 2026 |
| Ladenburg Thalmann |
Locked
➜
Locked
|
Locked | Jan 05 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 09 2025 |
| Maxim Group |
Locked
➜
Locked
|
Locked | Jul 18 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Maxim Group:
Locked
➜
Locked
|
Jul 20 2026 |
|
Locked
Maxim Group:
Locked
➜
Locked
|
Apr 08 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 01 2026 |
|
Locked
Ladenburg Thalmann:
Locked
➜
Locked
|
Jan 05 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 09 2025 |
|
Locked
Maxim Group:
Locked
➜
Locked
|
Jul 18 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


